Skip to main navigation Skip to search Skip to main content

A Phase III, Randomized, Placebo-Controlled, Blinded Investigation of Six Weeks Vs. Six Months of Oral Valganxixlovir Therapy in Infants with Symptomatic Congenital Cytomegalovirus Infection

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date07/1/07 → 07/31/13

Funding

  • National Institute of Allergy & Infectious Disease: $19,850.00